Hydrogenology
Hydrogenology editorial study record

Combination therapy of molecular hydrogen and hyperoxia improves survival rate and organ damage in a zymosan-induced generalized inflammation model

Hong Y, Sun L, Sun R, Chen H, Yu Y, Xie K. · Experimental and Therapeutic Medicine. 2016;11(6):2590-2596.

PreclinicalInhaled H₂Published 2016
Study record, not medical adviceThis page reports one source and Hydrogenology’s source-text extraction. It does not establish that molecular hydrogen is effective, safe or appropriate for any person. Human, animal and laboratory evidence must not be treated as equivalent.
Source and classification

What kind of evidence is this?

Evidence stream

Preclinical

Reported design

Randomized six-group controlled mouse experiment with separate survival and 24-hour organ-injury cohorts

Research topic

Critical care and ischemia-reperfusion

Administration classification

Inhaled H₂

Study result signal

Not reported in this record.

Outcome type

Not reported in this record.

Reported in the source

Methods at a glance

Population or model

Male ICR mice aged 6-8 weeks in a zymosan-induced generalized-inflammation and multiple-organ-damage model.

Sample

216 mice: 180 randomized to six groups of n=30 for 14-day survival and blood-gas assessment, plus 36 assigned to the same six groups of n=6 for 24-hour biochemical and histological outcomes.

Duration

Two three-hour exposures on the first day; organ outcomes at 24 hours and survival followed for 14 days.

Intervention

Two three-hour chamber exposures beginning one and six hours after zymosan. Groups received room air, 2% H₂ with 21% O₂, 98% O₂ alone, or 2% H₂ with 98% O₂.

Hydrogen form

Inhaled H₂/O₂/N₂ mixtures — not Brown's gas: neither the 2% H₂ + 21% O₂ mixture nor the 2% H₂ + 98% O₂ mixture has the 2:1 H₂:O₂ ratio.

H₂ specification

The source reports a total chamber inflow of 4 L/min. Thus the H₂ flow was 80 mL/min in both H₂ conditions. O₂ flow was 840 mL/min with 21% O₂ and 3,920 mL/min with 98% O₂; these are direct calculations from the reported total flow and compositions.

H₂ flow

80 mL/min.

O₂ delivered with H₂

840 mL/min in the 21% O₂ mixture; 3,920 mL/min in the 98% O₂ mixture.

Comparator

Normal-saline controls and zymosan-challenged mice exposed to room air, H₂ alone, hyperoxia alone, or the combined H₂/hyperoxia condition.

Reported, not endorsed

Outcomes and reported result

Outcomes measured

Fourteen-day survival, arterial blood gases, lung/liver/kidney histology, ALT, AST, creatinine, BUN, SOD, 8-iso-PGF2α, TNF-α and HMGB1.

Reported result

Survival after zymosan was 20% with room air, 70% with 2% H₂, 60% with 98% O₂ and 100% with the combined mixture. H₂ and hyperoxia each attenuated organ-injury and inflammatory/oxidative measures, with larger reported effects in combination. H₂ did not materially alter PaO₂, and arterial pH and PaCO₂ did not differ among groups.

Results-extraction completeness

The complete free PMC article was checked for allocation, both cohorts, exact gas compositions and total flow, directly calculated H₂/O₂ flows, timing, survival and organ outcomes, null blood-gas findings, funding and available disclosures.

A reported association, difference or mechanism is not automatically a clinical benefit. Null findings, outcome type, study design and precision all matter.

Interpretation limits

Cautions and applicability

Design and reporting cautions

Preclinical sterile-inflammation model, two short exposures, small n=6 organ-outcome groups, many surrogate comparisons and an extreme 98% O₂ condition. The article reports Chinese national, Tianjin and public-health grants; no explicit conflict statement was identified, so absence is not inferred.

Applies directly to

Experimental zymosan inflammation in male mice; it does not establish treatment of human sepsis or multiple-organ dysfunction.

Preliminary appraisal framework

Not reported in this record.

Preliminary risk-of-bias status

Not reported in this record.

Appraisal rationale

Not reported in this record.

No single-study GRADE certainty rating is assigned. Certainty is assessed by important outcome across a complete eligible evidence set, not by attaching a final grade to one source.

Provenance

Sources and record status

Identifiers

PMID: 27284352 · DOI: 10.3892/etm.2016.3231

Publisher access

Free full article in PubMed Central.

Extraction basis

Complete PMC article and PubMed metadata; full-text extraction checked 9 August 2026.

Record revision

2026-08-10